Loading...
In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome.
Todt, Daniel ; Gisa, Anett ; Radonic, Aleksandar ; Nitsche, Andreas ; Behrendt, Patrick ; Suneetha, Pothakamuri Venkata ; Pischke, Sven ; Bremer, Birgit ; Brown, Richard J P ; Manns, Michael P ... show 4 more
Todt, Daniel
Gisa, Anett
Radonic, Aleksandar
Nitsche, Andreas
Behrendt, Patrick
Suneetha, Pothakamuri Venkata
Pischke, Sven
Bremer, Birgit
Brown, Richard J P
Manns, Michael P
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2016-10
Submitted date
Files
Loading...
Open Access article
Adobe PDF, 1.29 MB
Other Titles
Abstract
Hepatitis E virus (HEV) infection can take chronic courses in immunocompromised patients potentially leading to liver cirrhosis and liver failure. Ribavirin (RBV) is currently the only treatment option for many patients, but treatment failure can occur which has been associated with the appearance of a distinct HEV polymerase mutant (G1634R). Here, we performed a detailed analysis of HEV viral intrahost evolution during chronic hepatitis E infections.
Citation
In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome. 2016, 65 (10):1733-43 Gut
Publisher
Journal
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Article
Language
en
Description
Series/Report no.
ISSN
1468-3288
